Delivering quality therapy since 1901
Skip Navigation LinksRichter Gedeon English About us Company's boards

Executive Board

  • Mr Erik Bogsch (1947)

    Chairman of the Company's Board of Directors. Responsible for Commercial, International and Governmental Affairs since November 1, 2017. Chemical engineer, qualified economic engineer. With Richter since 1970 in a number of Research and Development management positions. Medimpex director in Mexico from 1977 to 1983. Managing Director of Medimpex UK from 1988 to 1992. Member of the Board of MAGYOSZ, Chairman between 2006 and 2016.  Chief Executive Officer of Gedeon Richter from 1992 to November 2017.

  • Mr Gábor Orbán (1979)

    Appointed Chief Executive Officer from November 1, 2017. Began his professional career as an economist for the National Bank of Hungary and the European Central Bank. He later joined Aegon Asset Management where he worked as a fund manager and the head of the fixed income desk. He served as the state secretary in charge of taxation and the financial sector at the Minisrty for National Economy for two and a half years, followed by a year spent at Banque Rothschild where he worked as a consultant. He earned is MA degree at the Budapest University of Economics and studied also in the United States. Richter's Director of Corporate Strategy since September 2016, Chief Operating Officer since 2017. Member of the Company's Board of Directors from April 2017.

  • Dr Gábor Gulácsi (1958)

    Appointed Deputy Managing Director upon joining the Company in 2000. Responsible for Finance. Economist, University doctorate in Economic Sciences. Previously General Secretary of State, Ministry of Economic Affairs.​

  • Dr István Greiner (1960)

    Appointed Research Director in 2014. Chemical engineer (M.Sc), a qualified patent attorney, has a PhD and an MBA degree (Open University, UK). Joined Richter in 1984 and has held a number of management positions including Head of Chemical R&D, Head of the Patent Department between 1996 and 1999. In 2001 he was appointed Deputy to the Research Director and from 2006 he also became responsible for the new recombinant biotechnological activity of the Company.

  • Mr Tibor Horváth (1974)

    Appointed Commercial Director in 2017. Has an MSc in Biology and Chemisty and an MBA in Marketing and International Commerce. Joined Richter in 1999 as a market analyst then worked as a licensing manager. In 2005 he was appointed Managing Director of Richter's German subsidiary Gedeon Richter Pharma GmbH, where he worked until August 2017.

  • Dr György Thaler (1959)

    Appointed Development Director in 1993. Chemical engineer, University doctorate in Chemical Sciences. With Richter since 1983 in a number of management positions.​